Meeting
2011 ASCO Annual Meeting
Carcinoma of unknown primary site (CUP): Outcomes in patients with a colorectal molecular profile treated with site-specific chemotherapy.
Authors
F. A. Greco
Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN
F. A. Greco , W. J. Lennington , D. R. Spigel , G. R. Varadhachary , J. D. Hainsworth
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer
Citation
J Clin Oncol 29: 2011 (suppl; abstr 3563)
Abstract #
3563
Poster Bd #
13C
Abstract Disclosures
Similar Posters
Poster
2011 ASCO Annual Meeting
Molecular tumor profiling (MTP) in cancer of unknown primary site (CUP): A complement to standard pathologic diagnosis.
First Author: D. S. Thompson
Poster
2011 ASCO Annual Meeting
Patients with carcinoma of unknown primary with isolated carcinomatosis on presentation: Clinicopathologic features and survival data.
First Author: H. R. Carlson
Poster
2023 ASCO Annual Meeting
VIC regimen (vemurafenib/irinotecan/cetuximab) versus bevacizumab plus chemotherapy as first-line treatment for BRAF V600E-mutated advanced colorectal cancer.
First Author: Yijiao Chen
Poster
2023 ASCO Gastrointestinal Cancers Symposium
A meta-analysis of bevacizumab’s cardiovascular risks in patients treated for colorectal cancer.
First Author: Akshit Chitkara